Today, Neuraly announced its launch to pioneer the development of disease-modifying agents for neurodegenerative disorders. Read more >>
Scoop up the chili, fly with the Buffalo wings and pass the guacamole dip. For the first time in…
read moreEmovi announced today its partnership with TVM Capital Life Science and co-investors StandUp Ventures and Desjardins Capital to support…
read moreMyomo, Inc., a commercial stage medical robotics company with many connections in the greater Cleveland area, will be hosting…
read moreNow a new technology promises to lead him out of the dark. It’s called eSight, electronic glasses for the…
read moreSiamab Therapeutics, Inc., a biopharmaceutical company developing novel glycan-targeted cancer therapeutics, today announced the publication of new preclinical data…
read moreJDRF T1D Fund has made an undisclosed investment in TetraGenetics. Based in Arlington, Massachusetts, TetraGenetics is a biopharmaceutical company…
read moreWasabi provides “hot storage,” which means it’s fast to write, low-cost and reliable cloud storage. Read more >>
read moreSiamab Therapeutics, Inc. and Boehringer Ingelheim announced today that they have entered into a strategic discovery collaboration with the…
read moreeSight, the makers of the eSight electronic glasses, is permanently dropping the pricing of its eSight glasses from $10,000…
read moreSean Ainsworth hopes to strike biotech gold, again, joining Seattle-based Immusoft Corp. as CEO and chairman. Read more >>
read more